Research Article

Impact of Cypermethrin on Fingerlings of Common Edible Carp (Labeo rohita)

Table 3

Results of exposure of fish Labeo rohita fingerlings to cypermethrin for 96 h exposure periods.

ParametersTissuesControlDoses
0.082 μg/L (40% of 24 h LC50)0.164 μg/L (80% of 24 h LC50)

TPLiver 1 1 8 . 1 5 ± 0 . 3 0 (100) 8 8 . 6 1 ± 0 . 1 2 (75)abc 6 8 . 5 3 ± 0 . 1 3 (58)abc
Muscle 1 2 7 . 0 5 ± 0 . 2 8 (100) 8 8 . 9 4 ± 0 . 1 7 (70)abc 6 4 . 8 0 ± 0 . 2 2 (51)abc
FAALiver 7 . 0 5 ± 0 . 3 0 (100) 9 . 8 7 ± 0 . 1 7 (140)abc 1 3 . 4 0 ± 0 . 2 7 (190)abc
Muscle 1 2 . 9 0 ± 0 . 1 0 (100) 2 0 . 6 4 ± 0 . 1 5 (160)abc 2 7 . 0 9 ± 0 . 1 9 (210)abc
DNALiver 3 5 . 3 0 ± 0 . 1 2 (100) 2 9 . 3 0 ± 0 . 1 6 (83)abc 2 3 . 6 5 ± 0 . 1 2 (67)abc
Muscle 3 3 . 2 0 ± 0 . 3 5 (100) 2 3 . 2 4 ± 0 . 2 2 (70)abc 1 8 . 2 6 ± 0 . 1 6 (55)abc
RNALiver 3 6 . 8 0 ± 0 . 7 3 (100) 2 7 . 6 0 ± 0 . 2 4 (75)abc 2 2 . 0 8 ± 0 . 2 1 (60)abc
Muscle 3 7 . 2 0 ± 0 . 2 8 (100) 2 3 . 4 4 ± 0 . 1 8 (63)abc 1 8 . 9 7 ± 0 . 1 2 (51)abc
GYLiver 2 . 0 4 ± 0 . 0 7 (100) 1 . 6 6 ± 0 . 0 3 (83)abc 1 . 4 2 ± 0 . 0 5 (71)abc
Muscle 1 . 6 5 ± 0 . 0 9 (100) 1 . 3 2 ± 0 . 0 4 (80)abc 0 . 9 9 ± 0 . 0 3 (60)abc
PYLiver 1 . 9 9 ± 0 . 0 2 (100) 1 . 0 0 ± 0 . 0 1 (50)abc 0 . 8 8 ± 0 . 0 6 (44)abc
Muscle 1 . 5 0 ± 0 . 0 1 (100) 0 . 8 4 ± 0 . 0 3 (56)abc 0 . 7 8 ± 0 . 0 5 (52)abc
LALiver 1 . 4 4 ± 0 . 0 3 (100) 2 . 3 0 ± 0 . 0 8 (160)abc 2 . 6 5 ± 0 . 0 7 (184)abc
Muscle 1 . 2 5 ± 0 . 0 1 (100) 2 . 1 9 ± 0 . 0 4 (175)ab 2 . 3 8 ± 0 . 0 7 (190)ab
PRLiver 0 . 4 6 1 0 ± 0 . 0 6 (100) 0 . 6 2 2 4 ± 0 . 0 6 (135)abc 0 . 8 5 2 9 ± 0 . 0 3 (185)abc
Muscle 0 . 3 2 9 0 ± 0 . 0 9 (100) 0 . 4 7 3 8 ± 0 . 0 7 (144)abc 0 . 6 5 8 0 ± 0 . 0 3 (200)abc
ACLiver 0 . 1 3 3 ± 0 . 0 0 3 (100) 0 . 0 9 3 ± 0 . 0 5 (70)abc 0 . 0 7 7 ± 0 . 0 3 (58)abc
Muscle 0 . 1 3 0 ± 0 . 0 0 1 (100) 0 . 0 8 2 ± 0 . 0 5 (63)abc 0 . 0 6 5 ± 0 . 0 4 (50)abc
AKLiver 0 . 4 7 3 ± 0 . 0 0 4 (100) 0 . 3 8 8 ± 0 . 0 5 (82)abc 0 . 3 1 1 ± 0 . 0 7 (70)abc
Muscle 0 . 4 5 5 ± 0 . 0 0 3 (100) 0 . 3 3 2 ± 0 . 0 4 (73)abc 0 . 2 7 3 ± 0 . 0 2 (60)abc
ALATLiver 3 . 4 6 ± 0 . 3 0 (100) 5 . 5 4 ± 0 . 1 7 (160)abc 6 . 2 3 ± 0 . 1 1 (180)abc
Muscle 2 . 7 6 ± 0 . 1 1 (100) 4 . 5 8 ± 0 . 1 1 (166)abc 5 . 2 4 ± 0 . 1 2 (190)abc
AAT Liver 1 . 8 0 ± 0 . 0 9 (100) 2 . 6 1 ± 0 . 0 8 (145)abc 3 . 1 1 ± 0 . 0 6 (173)abc
Muscle 1 . 4 4 ± 0 . 0 8 (100) 2 . 2 3 ± 0 . 0 8 (155)abc 2 . 5 9 ± 0 . 0 3 (180)abc
AchE Liver 0 . 1 7 0 ± 0 . 0 3 (100) 0 . 0 6 0 ± 0 . 0 1 (35)abc 0 . 0 3 7 ± 0 . 0 3 (22)abc
Muscle 0 . 1 9 0 ± 0 . 0 4 (100) 0 . 0 6 8 ± 0 . 0 2 (36)abc 0 . 0 3 8 ± 0 . 0 5 (20)abc
CyO Liver 3 4 . 6 0 ± 0 . 2 0 (100) 2 4 . 2 2 ± 0 . 1 1 (70)abc 1 7 . 3 0 ± 0 . 1 3 (50)abc
Muscle 3 2 . 9 0 ± 0 . 2 2 (100) 2 0 . 0 7 ± 0 . 1 3 (61)abc 1 4 . 4 8 ± 0 . 1 2 (44)abc

Footnotes are same as given in Table 2.